Pharmaceutical Services

Health Monitor Network, a trusted leader in point of care (POC) marketing, announced the acquisition of D+R Lathian, an omnichannel healthcare marketing company known for its healthcare professional (HCP) digital engagement capabilities and proprietary MyDrugRep.com platform. The acquisition strengthens Health Monitor’s leadership in point of care by expanding its HCP engagement, data-driven activation and omnichannel

ROIS, a Global CDMO with its routes in Spain, announced on April 1st, the acquisition of a commercial injectable manufacturing and packaging facility in Phoenix, Arizona (USA). The move marks a key step in ROIS’s evolution into a global Contract Development and Manufacturing Organisation (CDMO), adding US-based sterile fill-finish capability while building on its strong

GI Partners, a leading private investment firm, announces it has completed the acquisition of the Contract Development and Manufacturing Organization (CDMO) and Cell Solutions businesses from Charles River Laboratories International, Inc., forming Rose BioSolutions (“Rose Bio”), a leading provider of advanced manufacturing capabilities across the cell and gene therapy space. As an independent company, Rose

CAI, a professional services firm dedicated to accelerating operational readiness and excellence in life sciences and mission-critical environments, announces that it has entered into an agreement with JLL Partners, a New York-based middle-market private equity firm focused on investing in the healthcare, industrials, and business services sectors, to support the next phase of growth for

Alcami Corporation (“Alcami”), a leading U.S.-based contract development and manufacturing organization (CDMO), announces the completion of the acquisition of Tjoapack, a leading global contract packaging organization with facilities in the United States and The Netherlands. The combined organization now employs over 1,400 skilled personnel across the U.S. and The Netherlands. This expands the operational footprint